New program supported by the Quebec Government and the City of Montreal looks to scale-up the province’s most promising young life sciences companies.
Montreal, QC – June 29th, 2020: adMare BioInnovations (adMare) is pleased to announce the creation of the adMare Accelerate Program for Quebec emerging companies. The Program is designed to advance a key pillar of adMare’s Mission: To help existing life sciences companies scale-up.
The adMare Accelerate Program for Quebec emerging companies is a unique two-year model through which up to eight selected pre-seed or seed-stage therapeutic, med-tech, or digital health companies undertaking their core activities in Quebec will receive up to $135,000 of in-kind customized adMare resources, thanks to the generous contributions of the Quebec Government and the City of Montreal. The selected companies will have access to adMare’s infrastructure and resources such as discounted laboratory and office space, complimentary scientific and business support, mentoring and training.
adMare is a single-stop destination with the necessary scientific, business, infrastructure and capital resources to drive health-related technology to a company of scale. We offer access to world-class, cross-disciplinary scientific and commercial expertise and infrastructure housed within our own state-of-the-art facilities, including the NÉOMED Innovation Center, as well as through our extended network of national and international partners.
“Our Vision is Canadian life sciences leading the world. To realize that Vision, adMare brings critical resources to the table that young companies could otherwise not access,” said Gordon C. McCauley, President and CEO of adMare BioInnovations. “We look forward to working closely with the selected companies in this Program, as well as all our partner companies across Canada, to help them grow into strong new Canadian anchors.”
“Programs like this are critical for the building of our commercial life sciences industry,” added Dr. Mounia Azzi, adMare’s Vice President of Program Development and Partnerships. “Together with Program delivery and Selection Committee partners, Montreal InVivo, Amplitude Ventures, the CTS, and Fonds de solidarité FTQ, we have an excellent opportunity to make a real impact on the scale-up of health-related technology companies in Quebec – and take a major step forward in establishing Canada as a global life sciences leader.”
The application deadline for the first cohort of the adMare Accelerate Program is August 14th, 2020. The eligible companies will be invited to present their business model to a selection committee. This program is open to companies headquartered anywhere in Canada, but they must be willing to undertake the majority of their activities at adMare’s NÉOMED Innovation Centre in Montreal, Quebec. For additional information on how adMare can support companies doing business in other parts of Canada, visit us at: www.admarebio.com/collaborating-with-admare/life-science-company-collaborations/.
Please visit here for further adMare Accelerate Program details and application form.